Whistleblower Law Collaborative Blog and News

Latest from Whistleblower Law Collaborative Blog and News

WLC is proud to announce that the government has intervened in a client’s qui tam case alleging violations of the incentive compensation ban.
On April 26, 2024, the United States partially intervened in a whistleblower-initiated False Claims Act (FCA) case alleging education fraud by Study Across the Pond (ATP).  ATP is an educational recruitment company.

Whistleblower Law Collaborative LLC is now representing whistleblowers in emerging new practice areas including cryptocurrency fraud, anti-money laundering and sanctions evasion, and cybersecurity fraud.  We celebrated our 20th anniversary in 2023 and continue our thriving practice under the False Claims Act and other whistleblower programs such as that of the SEC which has helped

According to a recent press release, the Department of Justice has filed a Complaint against New York-based Regeneron Pharmaceuticals Inc. (Regeneron) under the False Claims Act (FCA). The case involves Regeneron’s drug Eylea. Eylea is an anti-vascular endothelial growth factor inhibitor approved to treat neovascular Age-Related Macular Degeneration. The gravamen of the FCA case

The Commodity Futures Trading Commission (CFTC) released preliminary guidance regarding the trading of voluntary carbon credits on designated contract markets. This marks a notable step in enhancing the credibility and integrity of the voluntary carbon market. Before we delve into the details of the CFTC’s proposals, let’s first outline the significance of carbon offsetting,

Whistleblower Law Collaborative is proud to be a member of the whistleblower’s legal team in a recent municipal bond fraud settlement.  The $70 million qui tam settlement was with eight of the nation’s largest banks.  It is the largest reported settlement ever under the Illinois False Claims Act.
Largest Reported Recovery Under the Illinois False

In a landmark ruling, the U.S. Supreme Court delivered a significant victory for whistleblowers.  It affirmed that retaliatory intent is not a prerequisite for whistleblower protection under federal law. The unanimous decision, in favor of former UBS employee and whistleblower Trevor Murray (Murray), reinstated a $900,000 jury verdict.  In addition, the Court clarified an

The Department of Health and Human Services Office of Inspector General (OIG) recently issued Advisory Opinions 23-05 and 23-06 determining that two proposed physician joint ventures could run afoul of the federal Anti-Kickback Statute. The OIG explained in detail why the proposed physician joint ventures may not qualify for safe harbor protection. In addition,